Connecting clinical care, data and research
PartnershipsContact
← Back to publications

RESEARCH PUBLICATION / 2025

Original Article

Outcomes of SGLT2 inhibitors in heart transplant patients with diabetes

Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes.

Journal of internal medicine

Citation & Authors

J Intern Med. 2025;297(5):532-542.

Fu-Shun Yen; Yao-Min Hung; Jing-Yang Huang; Chih-Cheng Hsu; Wan-Yin Cheng; Chii-Min Hwu; James Cheng-Chung Wei

ABSTRACT · RESEARCH SUMMARY

Research summary

The study matched 1,063 pairs of patients with diabetes after heart transplantation. SGLT2 inhibitor users had lower risks of dialysis (HR 0.566; 95% CI 0.385–0.833), graft rejection/failure, hospitalization, and death. Infection/sepsis, ischemic heart disease, and worsening heart failure did not differ significantly. These multicenter observational findings do not establish causal benefit.

Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗